INSERM INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Patent Owner
Stats
- 19 US PATENTS IN FORCE
- 19 US APPLICATIONS PENDING
- Feb 22, 2018 most recent publication
Details
- 19 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 146 Total Citation Count
- Mar 09, 2001 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0036,427 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV INFECTIONMar 03, 16Feb 08, 18[A61K, C12N]
2018/0030,415 USE OF A LAMININ FOR DIFFERENTIATING PLURIPOTENT CELLS INTO HEPATOCYTE LINEAGE CELLSFeb 19, 16Feb 01, 18[C12N]
2018/0031,579 METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASEFeb 11, 16Feb 01, 18[A61K, G01N, C07K]
2017/0354,709 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEDec 23, 15Dec 14, 17[A61K]
2017/0211,043 METHOD FOR IN VITRO PRODUCTION OF ADIPOCYTE PROGENITORS AND ADIPOCYTESJul 28, 15Jul 27, 17[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9879090 Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin AMar 04, 14Jan 30, 18[A61K, C12N, G01N, C07K]
9856307 Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereofFeb 02, 15Jan 02, 18[A61K, G01N, C07K]
9840704 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloidsJul 30, 14Dec 12, 17[A61K, C07H, C12N, C07K]
9562018 Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the sameDec 27, 13Feb 07, 17[A61K, C07D]
9526725 Selective histamine H4 receptor antagonists for the treatment of vestibular disordersDec 23, 09Dec 27, 16[A61K, A01N, C07D]
9522218 Method for preparing porous scaffold for tissue engineering, cell culture and cell deliveryOct 10, 08Dec 20, 16[C08J, C12N, C08B, A61L]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0182,077 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedFeb 13, 15Jun 29, 17[A61K, C07K]
2015/0307,622 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASESAbandonedNov 08, 13Oct 29, 15[A61K, C12Q, C12N, G01N, C07K]
2015/0259,645 METHOD FOR INDUCING IL-2-FREE PROLIFERATION OF GAMMA DELTA T CELLSAbandonedNov 08, 13Sep 17, 15[A61K, C12N]
2015/0224,129 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTSAbandonedOct 01, 13Aug 13, 15[A61K]
2013/0336,937 CHONDROGENIC DIFFERENTIATION MEDIA AND METHODS FOR INDUCING CHONDROGENIC DIFFERENTIATION OF CELLSAbandonedMar 16, 12Dec 19, 13[C12N]
8487081 Antibodies specific for human hepcidinExpiredOct 02, 08Jul 16, 13[A61K, C07H, C12P, C12N, G01N, A61P, C07K]
2012/0094,312 BOOSTING HUMAN DENDRITIC CELL DEVELOPMENT, HOMEOSTASIS AND FUNCTION IN XENOGRAFTED IMMUNODEFICIENT MICEAbandonedApr 02, 10Apr 19, 12[A01K, G01N]
7959585 Device and method for the time-based analysis of the agitation of a bedridden patientExpiredSep 11, 07Jun 14, 11[A61B]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.